Clinical Trial Update: Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study of AZD5305 in combination with new hormonal agents for metastatic prostate cancer, currently active but n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• AZD5305 (AZD5305)

Snippet

Sponsor: AstraZeneca | Conditions: Metastatic Prostate Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING